Cargando…
Hypersensitivity to mesalazine in a patient with inflammatory bowel disease: a case report
A 32-year-old male presented with diarrhoea, mucus and bleeding per rectum. On the basis of sigmoidoscopy, rectal mesalazine was commenced uneventfully, and subsequently changed to oral mesalazine due to failure to improve. He re-presented 4 days later with frequent rigors, lethargy, palpitations an...
Autores principales: | Cronin, Kevin C, Colleran, Gabrielle C, Smyth, Andrew, Houlihan, Diarmuid D, O’Gorman, Thomas A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Cases Network Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769307/ https://www.ncbi.nlm.nih.gov/pubmed/19918537 http://dx.doi.org/10.4076/1757-1626-2-6715 |
Ejemplares similares
-
Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report
por: Smyth, Andrew, et al.
Publicado: (2010) -
Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease.
por: Mulder, C J, et al.
Publicado: (1998) -
Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
por: Matsumoto, Satohiro, et al.
Publicado: (2020) -
Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis
por: Zhang, Fen-Ming, et al.
Publicado: (2019) -
Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome
por: Dorofeyev, Andrey E, et al.
Publicado: (2011)